AN ACT Relating to enacting the protecting children's bodies act; 1
amending RCW 48.43.0128  and 74.09.675 ; adding a new section to 2
chapter 43.70  RCW ; creating a new section; and prescribing penalties. 3
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON: 4
NEW SECTION.   Sec. 1.  A new section is added to chapter 43.70 5
RCW to read as follows: 6
(1) A health care provider may not provide gender transition 7
procedures to any individual who is under 18 years of age. A health 8
care provider may not refer any individual who is under 18 years of 9
age to any health care provider for gender transition procedures. A 10
health care provider is not prohibited from providing any of the 11
following procedures that are not gender transition procedures to an 12
individual who is under 18 years of age: 13
(a) Services to persons born with a medically verifiable disorder 14
of sex development, including a person with external biological sex 15
characteristics that are irresolvably ambiguous, such as being born 16
with 46 xx chromosomes with virilization or 46 xy chromosomes with 17
undervirilization or having both ovarian and testicular tissue; 18
(b) Services provided when a physician has otherwise diagnosed a 19
disorder of sexual development and has determined through genetic or 20
biochemical testing that the person does not have normal sex 21H-0367.2
HOUSE BILL 1214
State of Washington 68th Legislature 2023 Regular Session
By Representative Walsh
p. 1 HB 1214chromosome structure, sex steroid hormone production, or sex steroid 1
hormone action; 2
(c) The treatment of any infection, injury, disease, or disorder 3
that has been caused by or exacerbated by the performance of gender 4
transition procedures, whether or not the gender transition procedure 5
was performed in accordance with state and federal law or whether or 6
not funding for the gender transition procedure is allowable under 7
this section; and 8
(d) Any procedure undertaken because the individual suffers from 9
a physical disorder, physical injury, or physical illness that would, 10
as certified by a physician, place the individual in imminent danger 11
of death or impairment of major bodily function unless surgery is 12
performed. 13
(2) Public funds may not be directly or indirectly used, granted, 14
paid, or distributed to any entity, organization, or individual that 15
provides gender transition procedures to an individual who is under 16
18 years of age. Health care services furnished in the following 17
situations may not include gender transition procedures to an 18
individual who is under 18 years of age: 19
(a) By or in a health care facility owned by this state or a 20
county or local government; and 21
(b) By a health care provider employed by the state or a county 22
or local government. 23
(3) Any referral for or provision of gender transition procedures 24
to an individual who is under 18 years of age is unprofessional 25
conduct and is subject to discipline by the appropriate disciplining 26
authority. 27
(4) A person may assert an actual or threatened violation of this 28
section as a claim or defense in a judicial or administrative 29
proceeding and obtain compensatory damages, injunctive relief, 30
declaratory relief, or any other appropriate relief. A person must 31
bring a claim for a violation of this section no later than two years 32
after the day the cause of action accrues. An individual who is under 33
18 years of age may bring an action throughout the individual's 34
minority through a parent or next friend and may bring an action in 35
the individual's own name on reaching 18 years of age until 20 years 36
after reaching 18 years of age. 37
(5) Notwithstanding any other law, an action under this section 38
may be commenced, and relief may be granted, in a judicial proceeding 39
without regard to whether the person commencing the action has sought 40
p. 2 HB 1214or exhausted available administrative remedies. In any action or 1
proceeding to enforce this section, a prevailing party who 2
establishes a violation of this section shall recover reasonable 3
attorney fees. 4
(6) The attorney general may bring an action to enforce 5
compliance with this section. This section does not deny, impair, or 6
otherwise affect any right or authority of the attorney general, this 7
state, or any agency, officer, or employee of this state, acting 8
under any law other than this section, to institute or intervene in 9
any proceeding. 10
(7) A violation of this section is a class C felony. 11
(8) For the purposes of this section: 12
(a) "Biological sex" means the biological indication of male and 13
female in the context of reproductive potential or capacity, such as 14
sex chromosomes, naturally occurring sex hormones, gonads and 15
nonambiguous internal and external genitalia present at birth, 16
without regard to an individual's psychological, chosen, or 17
subjective experience of gender. 18
(b) "Cross-sex hormones" means either of the following: 19
(i) Testosterone or other androgens given to biological females 20
in amounts that are larger or more potent than would normally occur 21
naturally in healthy biological sex females; or 22
(ii)  Estrogen given to biological males in amounts that are 23
larger or more potent than would normally occur naturally in healthy 24
biological sex males. 25
(c) "Gender" means the psychological, behavioral, social, and 26
cultural aspects of being male or female. 27
(d) "Gender reassignment surgery" means any medical or surgical 28
service that seeks to surgically alter or remove healthy physical or 29
anatomical characteristics or features that are typical for an 30
individual's biological sex in order to instill or create 31
physiological or anatomical characteristics that resemble a sex 32
different from the individual's biological sex. "Gender reassignment 33
surgery" includes genital or nongenital gender reassignment surgery 34
performed for the purpose of assisting an individual with a gender 35
transition. 36
(e) "Gender transition" means the process in which a person goes 37
from identifying with and living as a gender that corresponds to the 38
person's biological sex to identifying with and living as a gender 39
p. 3 HB 1214different from the person's biological sex and may involve social, 1
legal, or physical changes. 2
(f) "Gender transition procedures": 3
(i) Means any medical or surgical service, including physician 4
services, inpatient and outpatient hospital services, or prescribed 5
drugs related to gender transition, that seeks to either: 6
(A) Alter or remove physical or anatomical characteristics or 7
features that are typical for the individual's biological sex; or 8
(B) Instill or create physiological or anatomical characteristics 9
that resemble a sex different from the individual's biological sex, 10
including medical services that provide puberty-blocking drugs, 11
cross-sex hormones, or other mechanisms to promote the development of 12
feminizing or masculinizing features in the opposite biological sex 13
or genital or nongenital gender reassignment surgery performed for 14
the purpose of assisting an individual with a gender transition. 15
(ii)  Does not include any of the following: 16
(A) Services to persons born with a medically verifiable disorder 17
of sex development, including a person with external biological sex 18
characteristics that are irresolvably ambiguous, such as being born 19
with 46 xx chromosomes with virilization or 46 xy chromosomes with 20
undervirilization or having both ovarian and testicular tissue; 21
(B) Services provided when a physician has otherwise diagnosed a 22
disorder of sexual development and has determined through genetic or 23
biochemical testing that the person does not have normal sex 24
chromosome structure, sex steroid hormone production, or sex steroid 25
hormone action; 26
(C) The treatment of any infection, injury, disease, or disorder 27
that has been caused by or exacerbated by the performance of gender 28
transition procedures, whether or not the gender transition procedure 29
was performed in accordance with state and federal law or whether or 30
not funding for the gender transition procedure is allowable under 31
this section; and 32
(D) Any procedure undertaken because the individual suffers from 33
a physical disorder, physical injury, or physical illness that would, 34
as certified by a physician, place the individual in imminent danger 35
of death or impairment of major bodily function unless surgery is 36
performed. 37
(g) "Genital gender reassignment surgery" means a medical 38
procedure performed for the purpose of assisting an individual with a 39
gender transition, including any of the following: 40
p. 4 HB 1214(i) Surgical procedures such as penectomy, orchiectomy, 1
vaginoplasty, clitoroplasty, or vulvoplasty for biologically male 2
patients or hysterectomy or ovariectomy for biologically female 3
patients; 4
(ii)  Reconstruction of the fixed part of the urethra with or 5
without a metoidioplasty; 6
(iii)  Phalloplasty, vaginectomy, scrotoplasty, or implantation of 7
erection or testicular prostheses for biologically female patients; 8
and 9
(iv)  Removing any healthy or nondiseased body part. 10
(h) "Health care provider" means a person regulated under Title 11
18 RCW to practice health or health-related services or otherwise 12
practicing health care services in this state consistent with state 13
law. 14
(i) "Nongenital gender reassignment surgery" means medical 15
procedures performed for the purpose of assisting an individual with 16
a gender transition, including either of the following: 17
(i) Surgical procedures for biologically male patients, such as 18
augmentation mammoplasty, facial feminization surgery, liposuction, 19
lipofilling, voice surgery, thyroid cartilage reduction, gluteal 20
augmentation, hair reconstruction, or various aesthetic procedures; 21
and 22
(ii)  Surgical procedures for biologically female patients, such 23
as subcutaneous mastectomy, voice surgery, liposuction, lipofilling, 24
pectoral implants, or various aesthetic procedures. 25
(j) "Puberty-blocking drugs" means gonadotropin-releasing hormone 26
analogues or other synthetic drugs used in biological males to stop 27
luteinizing hormone secretion and testosterone secretion, or 28
synthetic drugs used in biological females which stop the production 29
of estrogens and progesterone, when used to delay or suppress 30
pubertal development in children for the purpose of assisting an 31
individual with a gender transition. 32
(k) "Public funds" means state, county, or local government 33
moneys, in addition to any department, agency, or instrumentality 34
authorized or appropriated under state law or derived from any fund 35
in which such moneys are deposited. 36
Sec. 2.  RCW 48.43.0128  and 2021 c 280 s 3 are each amended to 37
read as follows: 38
p. 5 HB 1214(1) A health carrier offering a nongrandfathered health plan or a 1
plan deemed by the commissioner to have a short-term limited purpose 2
or duration, or to be a student-only plan that is guaranteed 3
renewable while the covered person is enrolled as a regular, full- 4
time undergraduate student at an accredited higher education 5
institution may not: 6
(a) In its benefit design or implementation of its benefit 7
design, discriminate against individuals because of their age, 8
expected length of life, present or predicted disability, degree of 9
medical dependency, quality of life, or other health conditions; and 10
(b) With respect to the health plan or plan deemed by the 11
commissioner to have a short-term limited purpose or duration, or to 12
be a student-only plan that is guaranteed renewable while the covered 13
person is enrolled as a regular, full-time undergraduate student at 14
an accredited higher education institution, discriminate on the basis 15
of race, color, national origin, disability, age, sex, gender 16
identity, or sexual orientation. 17
(2) Nothing in this section may be construed to prevent a carrier 18
from appropriately utilizing reasonable medical management 19
techniques. 20
(3) ((For)) Except as provided in subsection (9) of this section, 21
for health plans issued or renewed on or after January 1, 2022: 22
(a) A health carrier may not deny or limit coverage for gender 23
affirming treatment when that treatment is prescribed to an 24
individual because of, related to, or consistent with a person's 25
gender expression or identity, as defined in RCW 49.60.040 , is 26
medically necessary, and is prescribed in accordance with accepted 27
standards of care. 28
(b) A health carrier may not apply categorical cosmetic or 29
blanket exclusions to gender affirming treatment. When prescribed as 30
medically necessary gender affirming treatment, a health carrier may 31
not exclude as cosmetic services facial feminization surgeries and 32
other facial gender affirming treatment, such as tracheal shaves, 33
hair electrolysis, and other care such as mastectomies, breast 34
reductions, breast implants, or any combination of gender affirming 35
procedures, including revisions to prior treatment. 36
(c) A health carrier may not issue an adverse benefit 37
determination denying or limiting access to gender affirming 38
services, unless a health care provider with experience prescribing 39
p. 6 HB 1214or delivering gender affirming treatment has reviewed and confirmed 1
the appropriateness of the adverse benefit determination. 2
(d) Health carriers must comply with all network access rules and 3
requirements established by the commissioner. 4
(4) For the purposes of this section, "gender affirming 5
treatment" means a service or product that a health care provider, as 6
defined in RCW 70.02.010 , prescribes to an individual to treat any 7
condition related to the individual's gender identity and is 8
prescribed in accordance with generally accepted standards of care. 9
Gender affirming treatment must be covered in a manner compliant with 10
the federal mental health parity and addiction equity act of 2008 and 11
the federal affordable care act. Gender affirming treatment can be 12
prescribed to two spirit, transgender, nonbinary, intersex, and other 13
gender diverse individuals. 14
(5) Nothing in this section may be construed to mandate coverage 15
of a service that is not medically necessary. 16
(6) By December 1, 2022, the commissioner, in consultation with 17
the health care authority and the department of health, must issue a 18
report on geographic access to gender affirming treatment across the 19
state. The report must include the number of gender affirming 20
providers offering care in each county, the carriers and medicaid 21
managed care organizations those providers have active contracts 22
with, and the types of services provided by each provider in each 23
region. The commissioner must update the report biannually and post 24
the report on its website. 25
(7) The commissioner shall adopt any rules necessary to implement 26
subsections (3), (4), and (5) of this section. 27
(8) Unless preempted by federal law, the commissioner shall adopt 28
any rules necessary to implement subsections (1) and (2) of this 29
section, consistent with federal rules and guidance in effect on 30
January 1, 2017, implementing the patient protection and affordable 31
care act. 32
(9) A health carrier may not reimburse or provide coverage for 33
gender affirming treatment to an individual who is under 18 years of 34
age. 35
Sec. 3.  RCW 74.09.675  and 2021 c 280 s 4 are each amended to 36
read as follows: 37
(1) ((In)) Except as provided in subsection (6) of this section, 38
in the provision of gender affirming care services through programs 39
p. 7 HB 1214under this chapter, the authority, managed care plans, and providers 1
that administer or deliver such services may not discriminate in the 2
delivery of a service provided through a program of the authority 3
based on the covered person's gender identity or expression. 4
(2) ((Beginning )) Except as provided in subsection (6) of this 5
section, beginning  January 1, 2022: 6
(a) The authority and any managed care plans delivering or 7
administering services purchased or contracted for by the authority 8
may not apply categorical cosmetic or blanket exclusions to gender 9
affirming treatment. 10
(b) Facial feminization surgeries and facial gender affirming 11
treatment, such as tracheal shaves, hair electrolysis, and other care 12
such as mastectomies, breast reductions, breast implants, or any 13
combination of gender affirming procedures, including revisions to 14
prior treatment, when prescribed as gender affirming treatment, may 15
not be excluded as cosmetic. 16
(c) The authority and managed care plans administering services 17
purchased or contracted for by the authority may not issue an adverse 18
benefit determination denying or limiting access to gender affirming 19
treatment, unless a health care provider with experience prescribing 20
or delivering gender affirming treatment has reviewed and confirmed 21
the appropriateness of the adverse benefit determination. 22
(d) If the authority and managed care plans administering 23
services purchased or contracted for by the authority do not have an 24
adequate network for gender affirming treatment, they shall ensure 25
the delivery of timely and geographically accessible medically 26
necessary gender affirming treatment at no greater expense than if 27
they had an in-network, geographically accessible provider available. 28
This includes, but is not limited to, providing case management 29
services to secure out-of-network gender affirming treatment options 30
that are available to the enrollee in a timely manner within their 31
geographic region. The enrollee shall pay no more than the same cost 32
sharing that the enrollee would pay for the same covered services 33
received from an in-network provider. 34
(3) For the purposes of this section, "gender affirming 35
treatment" means a service or product that a health care provider, as 36
defined in RCW 70.02.010 , prescribes to an individual to support and 37
affirm the individual's gender identity. Gender affirming treatment 38
includes, but is not limited to, treatment for gender dysphoria. 39
p. 8 HB 1214Gender affirming treatment can be prescribed to two spirit, 1
transgender, nonbinary, and other gender diverse individuals. 2
(4) Nothing in this section may be construed to mandate coverage 3
of a service that is not medically necessary. 4
(5) The authority shall adopt rules necessary to implement this 5
section. 6
(6) The authority and managed care plans administering services 7
purchased or contracted for by the authority may not reimburse or 8
provide coverage for gender affirming treatment to an individual who 9
is under 18 years of age. 10
NEW SECTION.   Sec. 4.  This act may be known and cited as the 11
protecting children's bodies act. 12
--- END ---
p. 9 HB 1214